Thank you, Boston! Biorasi had an amazing time at #OCT2025. If you missed connecting with us at the event, please reach out at >> https://lnkd.in/etU4dxq3 #Biorasi2025 #biotech #biopharma #clinicaltrials #CROs
About us
Biorasi is a global clinical research organization (CRO) that delivers speed-to-market strategies for small to midsized biotech and biopharma sponsors. With over two decades of expertise in running clinical trials across dermatology, oncology, neurology, nephrology, and other key therapeutic areas, Biorasi leverages reliable, flexible, and accessible solutions necessary to succeed in today's dynamic and evolving clinical trials industry. Our unique, full-service and standalone solutions have delivered results for five FDA-approved trials over the last seven years, multiple study rescues, and repeat business from our sponsors. Biorasi is the partner of choice for sponsors seeking a faster, more reliable, and more flexible path to clinical research success.
- Website
-
https://www.biorasi.com
External link for Biorasi
- Industry
- Research Services
- Company size
- 201-500 employees
- Headquarters
- Aventura, Florida
- Type
- Privately Held
- Founded
- 2002
- Specialties
- Contract Clinical Research, Complex Clinical Trials, Digital Therapeutics, Clinical Trial Rescue, Nephrology, Dermatology, Data Sciences, Clinical Trial Management, Neurology, Clinical Research Sites, Oncology, Decentralized Trials, Remote Solutions, Patient Centricity, Regenerative Medicine, Medical Device Clinical Trials, Innovative Project Management, Data Sciences, Biostatistics, and Study Rescue
Locations
-
Primary
Get directions
18851 NE 29th Ave
Suite 800
Aventura, Florida 33180, US
Employees at Biorasi
Updates
-
Biorasi reposted this
Fascinating article from past and future #FewAndFarBetween guest, Justin Stebbing and colleagues arguing that GLP-1 drugs mark the beginning of systems medicine, not "just" a weight-loss revolution.
Editor-in-Chief of Oncogene, Professor of Biomedical Sciences, ARU, Cambridge, Visiting Professor of Oncology, Imperial College, London, Phoenix Hospital Group, VP Graviton
beyond GLP-1s on a commentary I co-authored #teamwork
-
We are so excited about our new strategic partnership with Quotient Sciences. Connect with us to learn more!
Latest news: Quotient Sciences and Biorasi announced today a strategic partnership to deliver fully integrated early phase clinical trial solutions. Combining Quotient Sciences' expertise in early clinical development with Biorasi’s global patient recruitment capabilities, this collaboration addresses a growing demand for hybrid clinical trial designs that include both healthy volunteer studies and patient cohorts. Read the full announcement: https://bit.ly/4hiAaUk
-
-
BIG ANNOUNCEMENT! Biorasi is partnering with Quotient Sciences to deliver a streamlined pathway from first-in-human studies to patient proof-of-concept — all under a single CRO/CDMO model. You can read the full press release at >> https://lnkd.in/euR-cqUT #Biorasi2025 #CRO #CDMO #IND #clinicaltrials
-
-
Biorasi reposted this
Encouraging results — especially if these gains hold up across complex studies. The UK’s willingness to modernize regulation is setting a valuable precedent. Nice one, Stephen.
Impressive progress out of the UK MHRA has cut clinical trial approval times in half (from 91 to 41 days) through digital reform and AI-assisted review. Faster approvals mean faster access to potentially life-saving treatments, without compromising patient safety. It’s a strong reminder that innovation in how we review trials can be just as important as innovation in what we study. https://lnkd.in/gbmYzPAT
-
-
We’re at #OCT2025 New England this week. Meet up with Biorasi’s Nancy Newark and Rob Royall at Booth 17a to talk clinical trials, team collaboration, and quality data sciences solutions. Schedule time with our team >> https://lnkd.in/etU4dxq3 #Biorasi2025 #biotech #biopharma #clinicaltrials #CROs
-
-
#OCT2025 Boston is only a week away. Be sure to set your meetings with Rob Royall and Nancy Newark. We can't wait to see you!
Drawn to the “why” behind the numbers and science behind everything from drug development to a round of golf
Don’t gamble on your next clinical trial – just call Biorasi! #OCTNewEngland is right around the corner! Join us next week at Encore Boston Harbor to talk about how Biorasi delivers reliability, flexibility, and transparency to help sponsors win BIG! Stack your odds for clinical success! Connect with us in advance or stop by our booth – because when it comes to clinical trials, you can't leave anything to chance. 🎲 Nancy Newark #Biorasi #Innovation #Biotech #ClinicalTrials #Networking
-
-
"What they don’t do is anything to increase activation of Tregs and Bregs that naturally react to and shut down inflammation." How do you control an inflammatory cascade? Find out in our latest episode of the Biorasi Few & Far Between podcast. Host Chris O'Brien welcomes Woody Bryan, President and CEO at Revolo Biotherapeutics . Tune in today! Find this episode on your favorite streaming platform or visit >> https://lnkd.in/g2KE2SGA #Biorasi2025 #CRO #clinicaltrials #biotech #biopharma #autoimmune
-
NEWS ALERT: New Biorasi website drives reliable, flexible, and transparent #clinicaltrial solutions >> https://lnkd.in/eGNdZpTJ #Biorasi2025 #CROs #clinicalstudies #trialresuce #oncology #dermatology #neurology #nephrology #celltherapy #datasciences #biotech #biopharma
-
Today’s #clinicaltrials are more than meets the eye. 👁️ Behind every study is a #CRO team working collaboratively with stakeholders to drive enrollment, capture data, and meet critical milestones. Meet up with Biorasi’s Nancy Newark and Rob Royall at #OCT2025 New England this month to find out how our reliability, flexibility, and transparency deliver study results across multiple therapeutic areas – from oncology to dermatology and more. Schedule time with our team >> https://lnkd.in/etU4dxq3 #Biorasi2025 #biotech #biopharma
-